NFID

Board of Trustees

C. Douglas Webb, Jr. PhD

Retired
Chairman


John G. Bartlett, MD

Johns Hopkins Hospital

Tig Conger

Heritage Partners International

Emilio A. Emini, PhD

Wyeth Pharmaceuticals, Inc.

Jeffrey P. Engel, MD

North Carolina Department of Health and Human Services

Craig R. Engesser

Wyeth Pharmaceuticals, Inc.

Mark B. Feinberg, MD, PhD

Merck & Co.

Tobi Beth Karchmer, MD

BD Diagnostics

Bruce S. Lavin, MD, MPH

Aventis Pharmaceuticals

William J. Ledger, MD

New York -- Presbyterian Hospital, Weill Medical College of Cornell University

Edward B. Lewin, MD

Bethesda, MD

G. Lynn Marks, MD

GlaxoSmithKline, Inc.

William J. Martone, MD

MedImmune, Inc.

Sherri Michelstein

Alembic Health Communications

Kevin M. Rooney

Beacon Consulting Group

Frederick L. Ruben, MD

retired

Vijay Samant

Vical, Inc.

Leon G. Smith, MD, MACP

University of Medicine and Dentistry of New Jersey

Edmund C. Tramont, MD

National Institutes of Health

Lyn Wiesinger

Ardmore, PA

Executive Director

Len Novick


Modified June 2009